BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25707849)

  • 1. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway.
    Yi XP; Han T; Li YX; Long XY; Li WZ
    Mol Med Rep; 2015 Jul; 12(1):601-8. PubMed ID: 25707849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simultaneous inhibition of XIAP and survivin expression on EMT and invasion of human pancreatic cancer cells].
    Zai H; Yi X; Li Y; Jiang C; Lu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):883-8. PubMed ID: 23000761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.
    Yang J; Ouyang J; Ouyang L; Ouyang L; Chen Y
    Oncol Res; 2013; 21(1):43-50. PubMed ID: 24330851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.
    Jiang C; Yi XP; Shen H; Li YX
    World J Gastroenterol; 2012 Jun; 18(23):2956-65. PubMed ID: 22736919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
    Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
    Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
    Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.
    Jiang C; Tan T; Yi XP; Shen H; Li YX
    Mol Med Rep; 2011; 4(4):667-74. PubMed ID: 21479361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.
    Yin J; Li X; Zhang Z; Luo X; Wang L; Liu L
    Int J Oncol; 2018 Jul; 53(1):297-306. PubMed ID: 29749435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
    Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
    Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
    Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
    Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
    Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
    Zhu H; Qin H; Li DM; Liu J; Zhao Q
    Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
    Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
    Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Cao LP; Song JL; Yi XP; Li YX
    Oncol Rep; 2013 Apr; 29(4):1659-65. PubMed ID: 23354694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.
    Galloway NR; Aspe JR; Sellers C; Wall NR
    Pancreas; 2009 Oct; 38(7):782-90. PubMed ID: 19506533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway.
    Jin Y; Xu K; Chen Q; Wang B; Pan J; Huang S; Wei Y; Ma H
    Exp Cell Res; 2018 Jan; 362(2):362-369. PubMed ID: 29208461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.